A low monthly price can make GLP-1 treatments look simple. It rarely tells the full story. The medicine may be only one part of the cost, while the provider's clinical assessment, follow-up model, delivery arrangements and cancellation rules can make a meaningful difference to what you pay and the care you receive.

For anyone considering private weight-management treatment, the first question is not simply, “Which is cheapest?” It is whether a provider can show exactly what is included, who makes the prescribing decision and what happens if treatment is not approved or is no longer suitable.

What are GLP-1 treatments?

GLP-1 is short for glucagon-like peptide-1, a hormone involved in appetite regulation and blood-sugar control. Medicines that act on this pathway are prescription-only treatments. Some are licensed for weight management in defined circumstances, while others have different licensed indications. There are also medicines that act on more than one hormone pathway, which are often discussed alongside GLP-1 medicines.

The distinction matters. A medicine being widely discussed online does not mean it is appropriate, available or licensed for every purpose. A UK-registered prescriber must assess whether treatment can be prescribed based on your medical history, current medicines, eligibility criteria and other relevant information.

Private providers commonly begin with an online medical questionnaire. Depending on the provider and your circumstances, this may be followed by requests for additional information, photographs, a video consultation, contact with your GP or clinical checks during treatment. Completing a form is not a guarantee of approval.

Why headline prices for GLP-1 treatments mislead

Private treatment is often advertised using a starting monthly price. That figure may apply only to an introductory dose, a limited promotion or a particular medication. As treatment progresses, the medicine cost can change. It may also exclude charges that are unavoidable in practice.

Before comparing providers, check the total recurring cost at the dose prescribed, not just the first payment. Ask whether the displayed price includes the prescription, dispensing, delivery, clinical review and ongoing prescriber support. Some services include these items in one monthly price; others add fees at checkout or charge separately for consultations and assessments.

It is also worth checking whether a provider operates a subscription. A subscription is not automatically a problem, but its terms should be clear. Can you pause or cancel easily? Is there a notice period? Are refunds available if a clinician decides not to prescribe? Will the price change after an introductory period? These are commercial questions, but they affect whether treatment remains affordable and practical.

A fair comparison also accounts for the service around the medicine. One provider may cost more because it includes scheduled clinician reviews and a structured support programme. Another may be more basic, with clinical support available only when needed. Neither model is inherently better. The useful question is whether you understand what you are paying for and whether the provider delivers what it says it will.

What a proper clinical assessment should cover

GLP-1 medicines are not ordinary retail products. A legitimate provider should collect enough information for a prescriber to make an informed decision and should be willing to decline or pause treatment where appropriate.

Assessment processes vary, but they should examine relevant health history, medicines you take and potential safety concerns. A provider may need to clarify answers, request evidence of measurements or ask for information from your GP. This can feel slower than an instant approval, but a provider that performs no meaningful assessment is not offering reassurance.

Be especially cautious if a site appears to sell prescription medicine without a prescriber-led assessment, avoids questions about your health, or cannot explain who is responsible for your care. Never use a provider that cannot clearly confirm its regulatory status, the identity and registration of its prescribers, and the pharmacy supplying the medicine.

For online services, look for clear information about the clinical team, complaints process and how to seek help if you experience a problem. The provider should state how it handles follow-ups, not leave you to discover the answer after paying.

Side effects and monitoring are part of the decision

Like all prescription medicines, GLP-1 treatments can cause side effects and are not suitable for everyone. Gastrointestinal effects are commonly discussed, but the relevant risks and precautions depend on the individual medicine and your own circumstances. Read the patient information supplied with any prescribed treatment and raise concerns with the prescribing service or another appropriate clinician.

Monitoring is not a marketing extra. Its purpose is to help a clinician review tolerability, progress and whether it remains appropriate to continue. The level of follow-up required may differ between providers and patients. What matters is that it is clinically led, accessible and clearly priced.

Do not treat social-media claims, before-and-after photographs or anecdotes as a substitute for that process. They cannot tell you whether a medicine is suitable for you, nor can they show the full cost or quality of the provider behind the prescription.

Questions to ask before choosing a provider

A comparison is only useful if the details are like for like. Before starting a medical assessment, make sure you can answer these questions:

  • What is the monthly price for the treatment you may actually be prescribed, including later dose stages where prices differ?
  • Are consultation, prescribing, dispensing, delivery, follow-up reviews and any clinical checks included or charged separately?
  • Which UK-registered clinician reviews the assessment, and which regulated pharmacy dispenses the medicine?
  • What support is available between reviews, and what happens if you need to report side effects or ask a clinical question?
  • Can you cancel, pause or change your plan, and what refund policy applies if treatment is not approved or cannot be supplied?
  • Is the quoted price a short-term offer, and when might it change?

These questions protect against a familiar problem: choosing on the basis of a low first-month figure, then discovering extra costs or inflexible terms after treatment has begun.

Comparing medicine options without treating them as interchangeable

It is tempting to compare GLP-1 treatments as though they are simply different brand labels on the same product. They are not necessarily interchangeable. Licensed indications, active ingredients, administration schedules, supply and prescriber judgement can differ. The treatment a clinician may consider also depends on the information gathered during the assessment.

That means comparison should separate two decisions. First, compare providers: their transparency, total cost, clinical model, regulatory information and terms. Second, allow the prescriber to decide whether any treatment can be prescribed and, if so, which option is clinically appropriate.

This separation is useful because a comparison platform cannot replace a consultation. PickMyClinic can help make provider-set prices, included services and terms easier to compare, but it does not prescribe or decide eligibility. Those decisions belong with the regulated provider and its clinical team.

When cheap becomes expensive

The lowest headline price may still be good value, but only after the small print has been checked. A cheap plan can become costly if it excludes delivery, charges for every clinical review, raises prices sharply after a promotion or makes cancellation difficult. Conversely, a higher monthly figure may include support and follow-up that you would otherwise pay for separately.

Availability also matters. If a provider cannot explain how it manages supply disruption, substitutions or delayed deliveries, you may face inconvenience and uncertainty. No service can promise uninterrupted stock, but it should communicate honestly about what happens when supply changes.

The strongest choice is usually the provider that is clear before you pay: clear on full cost, clear on clinician oversight, clear on the pharmacy, and clear on what happens if the assessment does not lead to a prescription. Take the time to compare those fundamentals. They matter far more than a promotional price displayed in large type.